Amsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands.
Division of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.
J Thromb Haemost. 2021 Jul;19(7):1697-1708. doi: 10.1111/jth.15329. Epub 2021 May 1.
The prothrombinase complex consists of factors Xa (FXa) and Va (FVa) on an anionic phospholipid surface and converts prothrombin into thrombin. Both coagulation factors require activation before complex assembly. We recently identified TIX-5, a unique anticoagulant tick protein that specifically inhibits FXa-mediated activation of FV. Because TIX-5 inhibited thrombin generation in blood plasma, it was concluded that FV activation by FXa contributes importantly to coagulation.
We aimed to unravel the structure-function relationships of TIX-5.
We used a structure model generated based on homology with the allergen Der F7.
Tick inhibitor of factor Xa toward FV was predicted to consist of a single rod formed by several beta sheets wrapped around a central C-terminal alpha helix. By mutagenesis we could show that two hydrophobic loops at one end of the rod mediate the phospholipid binding of TIX-5. On the other end of the rod an FV interaction region was identified on one side, whereas on the other side an EGK sequence was identified that could potentially form a pseudosubstrate of FXa. All three interaction sites were important for the anticoagulant properties of TIX-5 in a tissue factor-initiated thrombin generation assay as well as in the inhibition of FV activation by FXa in a purified system.
The structure-function properties of TIX-5 are in perfect agreement with a protein that inhibits the FXa-mediated activation on a phospholipid surface. The present elucidation of the mechanism of action of TIX-5 will aid in deciphering the processes involved in the initiation phase of blood coagulation.
凝血酶原酶复合物由阴离子磷脂表面上的因子 Xa(FXa)和 Va(FVa)组成,并将凝血酶原转化为凝血酶。这两种凝血因子在复合物组装之前都需要激活。我们最近发现了 TIX-5,一种独特的抗凝蜱蛋白,它特异性抑制 FXa 介导的 FV 激活。由于 TIX-5 抑制了血浆中的凝血酶生成,因此可以得出结论,FXa 介导的 FV 激活对凝血具有重要作用。
我们旨在揭示 TIX-5 的结构-功能关系。
我们使用基于过敏原 Der F7 的同源性生成的结构模型。
预测 tick inhibitor of factor Xa toward FV 由几个β片层包裹在中央 C 末端α螺旋周围形成的单个棒组成。通过突变我们可以证明,棒的一端的两个疏水性环介导了 TIX-5 的磷脂结合。在棒的另一端,在一侧鉴定了一个 FV 相互作用区域,而在另一侧鉴定了一个潜在的 FXa 伪底物的 EGK 序列。在组织因子启动的凝血酶生成测定中以及在纯化系统中抑制 FXa 介导的 FV 激活中,所有三个相互作用位点对 TIX-5 的抗凝特性都很重要。
TIX-5 的结构-功能特性与一种抑制磷脂表面上 FXa 介导的激活的蛋白质完全一致。目前对 TIX-5 作用机制的阐明将有助于破译血液凝固起始阶段涉及的过程。